Browse Drug Recalls
41 FDA drug safety recalls.
FDA Drug Recall Enforcement Database
Browse 41 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.
Drug Safety Recalls
Browse 41 FDA drug recalls.
| Date | Product | Reason | Class | Firm |
|---|---|---|---|---|
| Feb 6, 2023 | Levothyroxine Sodium Tablets, USP 112 mcg, 90 tablets per bottle, Rx Only, Ma... | Sub-Potent Drug: Out of specification for assay at the 24 month interval. | Class II | Alvogen, Inc |
| Apr 1, 2013 | Lloyd Thyro-Tab 0.200 mg., packaged in 150,000-tablet bulk drums (2/75,000-ta... | cGMP deviations; After quality review of stability failures in previous lots, there is insufficie... | Class II | Lloyd Inc. of Iowa |
| Apr 1, 2013 | Levothroid (levothyroxine sodium tablets, USP), 175 mcg, RX only, 100 tablets... | cGMP deviations; After quality review of stability failures in previous lots, there is insufficie... | Class II | Lloyd Inc. of Iowa |
| Apr 1, 2013 | Lloyd Thyro-Tab 0.175 mg., packaged in 150,000-tablet bulk drums (2/75,000-ta... | cGMP deviations; After quality review of stability failures in previous lots, there is insufficie... | Class II | Lloyd Inc. of Iowa |
| Apr 1, 2013 | Lloyd Thyro-Tab 0.137 mg., packaged in 150,000-tablet bulk drums (2/75,000-ta... | cGMP deviations; After quality review of stability failures in previous lots, there is insufficie... | Class II | Lloyd Inc. of Iowa |
| Apr 1, 2013 | Levothroid (levothyroxine sodium tablets, USP) , 125 mcg, RX only, 100 tablet... | cGMP deviations; After quality review of stability failures in previous lots, there is insufficie... | Class II | Lloyd Inc. of Iowa |
| Apr 1, 2013 | Lloyd Thyro-Tab 0.100 mg., packaged in 150,000-tablet bulk drums (2/75,000-ta... | cGMP deviations; After quality review of stability failures in previous lots, there is insufficie... | Class II | Lloyd Inc. of Iowa |
| Apr 1, 2013 | Lloyd Thyro-Tab 0.125 mg., packaged in 150,000-tablet bulk drums (2/75,000-ta... | cGMP deviations; After quality review of stability failures in previous lots, there is insufficie... | Class II | Lloyd Inc. of Iowa |
| Apr 1, 2013 | Lloyd Thyro-Tab 0.088 mg., packaged in 150,000-tablet bulk drums (2/75,000-ta... | cGMP deviations; After quality review of stability failures in previous lots, there is insufficie... | Class II | Lloyd Inc. of Iowa |
| Apr 1, 2013 | Levothroid (levothyroxine sodium tablets, USP) , 75 mcg, RX only, 100 tablets... | cGMP deviations; After quality review of stability failures in previous lots, there is insufficie... | Class II | Lloyd Inc. of Iowa |
| Apr 1, 2013 | Levothroid (levothyroxine sodium tablets, USP), 100 mcg, RX only, 100 tablets... | cGMP deviations; After quality review of stability failures in previous lots, there is insufficie... | Class II | Lloyd Inc. of Iowa |
| Apr 1, 2013 | Lloyd Thyro-Tab 0.112 mg., packaged in 150,000-tablet bulk drums (2/75,000-ta... | cGMP deviations; After quality review of stability failures in previous lots, there is insufficie... | Class II | Lloyd Inc. of Iowa |
| Apr 1, 2013 | Lloyd Thyro-Tab 0.075 mg., packaged in 150,000-tablet bulk drums (2/75,000-ta... | cGMP deviations; After quality review of stability failures in previous lots, there is insufficie... | Class II | Lloyd Inc. of Iowa |
| Apr 1, 2013 | Levothroid (levothyroxine sodium tablets, USP), 200 mcg, RX only, 100 tablets... | cGMP deviations; After quality review of stability failures in previous lots, there is insufficie... | Class II | Lloyd Inc. of Iowa |
| Apr 1, 2013 | Levothroid (levothyroxine sodium tablets, USP), 88 mcg, RX only, 100 tablets ... | cGMP deviations; After quality review of stability failures in previous lots, there is insufficie... | Class II | Lloyd Inc. of Iowa |
| Apr 1, 2013 | Levothroid (levothyroxine sodium tablets, USP) , 50 mcg, RX only, 100 tablets... | cGMP deviations; After quality review of stability failures in previous lots, there is insufficie... | Class II | Lloyd Inc. of Iowa |
| Apr 1, 2013 | Levothroid (levothyroxine sodium tablets, USP), 150 mcg, RX only, 100 tablets... | cGMP deviations; After quality review of stability failures in previous lots, there is insufficie... | Class II | Lloyd Inc. of Iowa |
| Apr 1, 2013 | Levothroid (levothyroxine sodium tablets, USP), 112 mcg, RX only, 100 tablets... | cGMP deviations; After quality review of stability failures in previous lots, there is insufficie... | Class II | Lloyd Inc. of Iowa |
| Apr 1, 2013 | Levothroid (levothyroxine sodium tablets, USP), 137 mcg, RX only, 100 tablets... | cGMP deviations; After quality review of stability failures in previous lots, there is insufficie... | Class II | Lloyd Inc. of Iowa |
| Apr 1, 2013 | Lloyd Thyro-Tab 0.150 mg., packaged in 150,000-tablet bulk drums (2/75,000-ta... | cGMP deviations; After quality review of stability failures in previous lots, there is insufficie... | Class II | Lloyd Inc. of Iowa |
| Apr 1, 2013 | Lloyd Thyro-Tab 0.050 mg., packaged in 150,000-tablet bulk drums (2/75,000-ta... | cGMP deviations; After quality review of stability failures in previous lots, there is insufficie... | Class II | Lloyd Inc. of Iowa |
| Jul 25, 2012 | Thyro-Tab 0.050 mg., packaged in 150,000-tablet bulk drums for repackaging, R... | Subpotent; 9-month stability interval | Class II | Lloyd Inc. of Iowa |
| Jul 25, 2012 | Thyro-Tab 0.075 mg., packaged in 150,000-tablet bulk drums for repackaging, R... | Subpotent; 9-month stability interval | Class II | Lloyd Inc. of Iowa |
| Jul 25, 2012 | Levothroid (levothyroxine sodium tablets, USP), 50 mcg., 100-count bottles, R... | Subpotent; 9-month stability interval | Class II | Lloyd Inc. of Iowa |
| Jul 25, 2012 | Levothroid (levothyroxine sodium tablets, USP), 75 mcg., 100-count bottles, R... | Subpotent; 9-month stability interval | Class II | Lloyd Inc. of Iowa |
| Jul 9, 2012 | Thyro-Tab 0.088 mg., packaged in 150,000-tablet bulk drums for repackaging, R... | cGMP Deviations; does not meet in process specification requirements | Class II | Lloyd Inc. of Iowa |
| Jul 9, 2012 | Thyro-Tab 0.300 mg., packaged in 150,000-tablet bulk drums for repackaging, R... | cGMP Deviations; does not meet in process specification requirements | Class II | Lloyd Inc. of Iowa |
| Jul 9, 2012 | Thyro-Tab 0.125 mg., packaged in 150,000-tablet bulk drums for repackaging, R... | cGMP Deviations; does not meet in process specification requirements | Class II | Lloyd Inc. of Iowa |
| Jul 9, 2012 | Levothroid (levothyroxine sodium tablets, USP), 50 mcg., 100-count bottles, R... | cGMP Deviations; does not meet in process specification requirements | Class II | Lloyd Inc. of Iowa |
| Jul 9, 2012 | Thyro-Tab 0.112 mg., packaged in 150,000-tablet bulk drums for repackaging, R... | cGMP Deviations; does not meet in process specification requirements | Class II | Lloyd Inc. of Iowa |
| Jul 9, 2012 | Levothroid (levothyroxine sodium tablets, USP), 300 mcg., 100-count bottles, ... | cGMP Deviations; does not meet in process specification requirements | Class II | Lloyd Inc. of Iowa |
| Jul 9, 2012 | Thyro-Tab 0.050 mg., packaged in 150,000-tablet bulk drums for repackaging, R... | cGMP Deviations; does not meet in process specification requirements | Class II | Lloyd Inc. of Iowa |
| Jul 9, 2012 | Levothroid (levothyroxine sodium tablets, USP), 88 mcg., 100-count bottles, R... | cGMP Deviations; does not meet in process specification requirements | Class II | Lloyd Inc. of Iowa |
| Jul 9, 2012 | Levothroid (levothyroxine sodium tablets, USP),125 mcg., 100-count bottles, R... | cGMP Deviations; does not meet in process specification requirements | Class II | Lloyd Inc. of Iowa |
| Jul 9, 2012 | Thyro-Tab 0.137 mg., packaged in 150,000-tablet bulk drums for repackaging, R... | cGMP Deviations; does not meet in process specification requirements | Class II | Lloyd Inc. of Iowa |
| Jul 9, 2012 | Levothroid (levothyroxine sodium tablets, USP), 137 mcg., 100-count bottles, ... | cGMP Deviations; does not meet in process specification requirements | Class II | Lloyd Inc. of Iowa |
| Jul 9, 2012 | Levothroid (levothyroxine sodium tablets, USP), 112 mcg., 100-count bottles, ... | cGMP Deviations; does not meet in process specification requirements | Class II | Lloyd Inc. of Iowa |
| Feb 24, 2012 | Levothroid (levothyroxine sodium tablets, USP), 75 mcg., 100-count bottles, R... | Subpotent (Single Ingredient Drug): Low assay at the 6-month test interval. | Class II | Lloyd Inc |
| Feb 24, 2012 | Thyro-Tab.075 mg., packaged in bulk drums for repackaging. The firm name on t... | Subpotent (Single Ingredient Drug): Low assay at the 6-month test interval. | Class II | Lloyd Inc |
| Feb 3, 2012 | Levothroid (levothyroxine sodium tablets, USP), 50 mcg., packaged in 100-ct. ... | Subpotent (Single Ingredient Drug): Low assay at the 9-month test interval. | Class II | Lloyd Inc |
| Feb 3, 2012 | Thyro-Tab 0.050mg., packaged in bulk drums for repackaging. The firm name on... | Subpotent (Single Ingredient Drug): Low assay at the 9-month test interval. | Class II | Lloyd Inc |
Frequently Asked Questions
When a drug safety issue is identified — through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks — the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.
The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.
Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.